Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shenzhen
  • Sector: Materials
  • Industry: Chemicals
  • Sub-Industry: Basic & Diversified Chemicals

Hubei Biocause Pharmaceutical Co Ltd

+ Add to Watchlist

000627:CH

10.960 CNY 0.160 1.44%

As of 03:00:28 ET on 03/27/2015.

Snapshot for Hubei Biocause Pharmaceutical Co Ltd (000627)

Open: 11.090 Day's Range: 10.900 - 11.190 Volume: 48,108,782
Previous Close: 11.120 52wk Range: 2.400 - 11.970 1-Yr Rtn: +312.03%

Stock Chart for 000627

No chart data available.
  • 000627:CH 10.960
  • 1D
  • 1M
  • 1Y
11.120
Interactive 000627 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 000627

Current P/E Ratio (ttm) 169.8198
Estimated P/E(-) -
Relative P/E vs. SZASHR 3.4889
Earnings Per Share (ttm) 0.0645
Est. EPS -
Est. PEG Ratio -
Market Cap (M CNY) 14,835.35
Shares Outstanding (M) 1,353.59
30 Day Average Volume 106,878,500
Price/Book (mrq) 10.2382
Price/Sale (ttm) 18.4350
Dividend Indicated Gross Yield -%
Cash Dividend (CNY) 0.0085
Dividend Ex-Date 04/12/2010
5 Year Dividend Growth -
Next Earnings Announcement 04/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 000627

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 000627

Hubei Biocause Pharmaceutical Co., Ltd. develops and produces pharmaceuticals focusing on the treatment of colonitis, high blood pressure, and infectious diseases. The Company also manufactures and markets carbinol and polypropylene chemical products.

Xiao YunhuaChairman/PresidentChen DaliVice Chairman
Liu BinVice PresidentYi TinghaoController/Secretary
More Company Profile & Key Executives for 000627

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil